 | • レポートコード：QYR2104Z1015 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、気管支炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗炎症薬、気管支拡張薬、粘液溶解薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・気管支炎の市場動向 ・企業の競争状況、市場シェア ・気管支炎の種類別市場規模（抗生物質、抗炎症薬、気管支拡張薬、粘液溶解薬） ・気管支炎の用途別市場規模（病院、クリニック、その他） ・気管支炎の北米市場規模2016-2027（アメリカ、カナダ） ・気管支炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・気管支炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・気管支炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・気管支炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boehringer Ingelheim、Dr. Reddy’s Laboratories、GlaxoSmithKline Pharmaceuticals、Pfizer、Sanofi Aventis） ・結論 |
Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the lungs. Symptoms include coughing up mucus, wheezing, shortness of breath, and chest discomfort. Bronchitis is divided into two types: acute and chronic. Acute bronchitis is also known as a chest cold.
Market Analysis and Insights: Global Bronchitis Market
The global Bronchitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bronchitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bronchitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bronchitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bronchitis market.
Global Bronchitis Scope and Market Size
Bronchitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bronchitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotics
Anti-Inflammatory Drugs
Bronchodilators
Mucolytics
Segment by Application
Hospital
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Boehringer Ingelheim
Dr. Reddy’s Laboratories
GlaxoSmithKline Pharmaceuticals
Pfizer
Sanofi Aventis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Anti-Inflammatory Drugs
1.2.4 Bronchodilators
1.2.5 Mucolytics
1.3 Market by Application
1.3.1 Global Bronchitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bronchitis Market Perspective (2016-2027)
2.2 Bronchitis Growth Trends by Regions
2.2.1 Bronchitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bronchitis Historic Market Share by Regions (2016-2021)
2.2.3 Bronchitis Forecasted Market Size by Regions (2022-2027)
2.3 Bronchitis Industry Dynamic
2.3.1 Bronchitis Market Trends
2.3.2 Bronchitis Market Drivers
2.3.3 Bronchitis Market Challenges
2.3.4 Bronchitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bronchitis Players by Revenue
3.1.1 Global Top Bronchitis Players by Revenue (2016-2021)
3.1.2 Global Bronchitis Revenue Market Share by Players (2016-2021)
3.2 Global Bronchitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bronchitis Revenue
3.4 Global Bronchitis Market Concentration Ratio
3.4.1 Global Bronchitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchitis Revenue in 2020
3.5 Bronchitis Key Players Head office and Area Served
3.6 Key Players Bronchitis Product Solution and Service
3.7 Date of Enter into Bronchitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchitis Breakdown Data by Type
4.1 Global Bronchitis Historic Market Size by Type (2016-2021)
4.2 Global Bronchitis Forecasted Market Size by Type (2022-2027)
5 Bronchitis Breakdown Data by Application
5.1 Global Bronchitis Historic Market Size by Application (2016-2021)
5.2 Global Bronchitis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bronchitis Market Size (2016-2027)
6.2 North America Bronchitis Market Size by Type
6.2.1 North America Bronchitis Market Size by Type (2016-2021)
6.2.2 North America Bronchitis Market Size by Type (2022-2027)
6.2.3 North America Bronchitis Market Size by Type (2016-2027)
6.3 North America Bronchitis Market Size by Application
6.3.1 North America Bronchitis Market Size by Application (2016-2021)
6.3.2 North America Bronchitis Market Size by Application (2022-2027)
6.3.3 North America Bronchitis Market Size by Application (2016-2027)
6.4 North America Bronchitis Market Size by Country
6.4.1 North America Bronchitis Market Size by Country (2016-2021)
6.4.2 North America Bronchitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bronchitis Market Size (2016-2027)
7.2 Europe Bronchitis Market Size by Type
7.2.1 Europe Bronchitis Market Size by Type (2016-2021)
7.2.2 Europe Bronchitis Market Size by Type (2022-2027)
7.2.3 Europe Bronchitis Market Size by Type (2016-2027)
7.3 Europe Bronchitis Market Size by Application
7.3.1 Europe Bronchitis Market Size by Application (2016-2021)
7.3.2 Europe Bronchitis Market Size by Application (2022-2027)
7.3.3 Europe Bronchitis Market Size by Application (2016-2027)
7.4 Europe Bronchitis Market Size by Country
7.4.1 Europe Bronchitis Market Size by Country (2016-2021)
7.4.2 Europe Bronchitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bronchitis Market Size (2016-2027)
8.2 Asia-Pacific Bronchitis Market Size by Type
8.2.1 Asia-Pacific Bronchitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bronchitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bronchitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Bronchitis Market Size by Application
8.3.1 Asia-Pacific Bronchitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bronchitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bronchitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Bronchitis Market Size by Region
8.4.1 Asia-Pacific Bronchitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bronchitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bronchitis Market Size (2016-2027)
9.2 Latin America Bronchitis Market Size by Type
9.2.1 Latin America Bronchitis Market Size by Type (2016-2021)
9.2.2 Latin America Bronchitis Market Size by Type (2022-2027)
9.2.3 Latin America Bronchitis Market Size by Type (2016-2027)
9.3 Latin America Bronchitis Market Size by Application
9.3.1 Latin America Bronchitis Market Size by Application (2016-2021)
9.3.2 Latin America Bronchitis Market Size by Application (2022-2027)
9.3.3 Latin America Bronchitis Market Size by Application (2016-2027)
9.4 Latin America Bronchitis Market Size by Country
9.4.1 Latin America Bronchitis Market Size by Country (2016-2021)
9.4.2 Latin America Bronchitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bronchitis Market Size (2016-2027)
10.2 Middle East & Africa Bronchitis Market Size by Type
10.2.1 Middle East & Africa Bronchitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bronchitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bronchitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Bronchitis Market Size by Application
10.3.1 Middle East & Africa Bronchitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bronchitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bronchitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Bronchitis Market Size by Country
10.4.1 Middle East & Africa Bronchitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bronchitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Bronchitis Introduction
11.1.4 Boehringer Ingelheim Revenue in Bronchitis Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Dr. Reddy’s Laboratories
11.2.1 Dr. Reddy’s Laboratories Company Details
11.2.2 Dr. Reddy’s Laboratories Business Overview
11.2.3 Dr. Reddy’s Laboratories Bronchitis Introduction
11.2.4 Dr. Reddy’s Laboratories Revenue in Bronchitis Business (2016-2021)
11.2.5 Dr. Reddy’s Laboratories Recent Development
11.3 GlaxoSmithKline Pharmaceuticals
11.3.1 GlaxoSmithKline Pharmaceuticals Company Details
11.3.2 GlaxoSmithKline Pharmaceuticals Business Overview
11.3.3 GlaxoSmithKline Pharmaceuticals Bronchitis Introduction
11.3.4 GlaxoSmithKline Pharmaceuticals Revenue in Bronchitis Business (2016-2021)
11.3.5 GlaxoSmithKline Pharmaceuticals Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bronchitis Introduction
11.4.4 Pfizer Revenue in Bronchitis Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanofi Aventis
11.5.1 Sanofi Aventis Company Details
11.5.2 Sanofi Aventis Business Overview
11.5.3 Sanofi Aventis Bronchitis Introduction
11.5.4 Sanofi Aventis Revenue in Bronchitis Business (2016-2021)
11.5.5 Sanofi Aventis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bronchitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Anti-Inflammatory Drugs
Table 4. Key Players of Bronchodilators
Table 5. Key Players of Mucolytics
Table 6. Global Bronchitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bronchitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bronchitis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bronchitis Market Share by Regions (2016-2021)
Table 10. Global Bronchitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bronchitis Market Share by Regions (2022-2027)
Table 12. Bronchitis Market Trends
Table 13. Bronchitis Market Drivers
Table 14. Bronchitis Market Challenges
Table 15. Bronchitis Market Restraints
Table 16. Global Bronchitis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bronchitis Market Share by Players (2016-2021)
Table 18. Global Top Bronchitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchitis as of 2020)
Table 19. Ranking of Global Top Bronchitis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bronchitis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bronchitis Product Solution and Service
Table 23. Date of Enter into Bronchitis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bronchitis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bronchitis Revenue Market Share by Type (2016-2021)
Table 27. Global Bronchitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bronchitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bronchitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bronchitis Revenue Market Share by Application (2016-2021)
Table 31. Global Bronchitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bronchitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bronchitis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bronchitis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bronchitis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bronchitis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bronchitis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bronchitis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bronchitis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bronchitis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bronchitis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bronchitis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bronchitis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bronchitis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bronchitis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bronchitis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bronchitis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bronchitis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bronchitis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bronchitis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bronchitis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bronchitis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bronchitis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bronchitis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bronchitis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bronchitis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bronchitis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bronchitis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bronchitis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bronchitis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bronchitis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bronchitis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Boehringer Ingelheim Company Details
Table 64. Boehringer Ingelheim Business Overview
Table 65. Boehringer Ingelheim Bronchitis Product
Table 66. Boehringer Ingelheim Revenue in Bronchitis Business (2016-2021) & (US$ Million)
Table 67. Boehringer Ingelheim Recent Development
Table 68. Dr. Reddy’s Laboratories Company Details
Table 69. Dr. Reddy’s Laboratories Business Overview
Table 70. Dr. Reddy’s Laboratories Bronchitis Product
Table 71. Dr. Reddy’s Laboratories Revenue in Bronchitis Business (2016-2021) & (US$ Million)
Table 72. Dr. Reddy’s Laboratories Recent Development
Table 73. GlaxoSmithKline Pharmaceuticals Company Details
Table 74. GlaxoSmithKline Pharmaceuticals Business Overview
Table 75. GlaxoSmithKline Pharmaceuticals Bronchitis Product
Table 76. GlaxoSmithKline Pharmaceuticals Revenue in Bronchitis Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Pharmaceuticals Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Bronchitis Product
Table 81. Pfizer Revenue in Bronchitis Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Sanofi Aventis Company Details
Table 84. Sanofi Aventis Business Overview
Table 85. Sanofi Aventis Bronchitis Product
Table 86. Sanofi Aventis Revenue in Bronchitis Business (2016-2021) & (US$ Million)
Table 87. Sanofi Aventis Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchitis Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Anti-Inflammatory Drugs Features
Figure 4. Bronchodilators Features
Figure 5. Mucolytics Features
Figure 6. Global Bronchitis Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Bronchitis Report Years Considered
Figure 11. Global Bronchitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bronchitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bronchitis Market Share by Regions: 2020 VS 2027
Figure 14. Global Bronchitis Market Share by Regions (2022-2027)
Figure 15. Global Bronchitis Market Share by Players in 2020
Figure 16. Global Top Bronchitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchitis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bronchitis Revenue in 2020
Figure 18. Global Bronchitis Revenue Market Share by Type (2016-2021)
Figure 19. Global Bronchitis Revenue Market Share by Type (2022-2027)
Figure 20. North America Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bronchitis Market Share by Type (2016-2027)
Figure 22. North America Bronchitis Market Share by Application (2016-2027)
Figure 23. North America Bronchitis Market Share by Country (2016-2027)
Figure 24. United States Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bronchitis Market Share by Type (2016-2027)
Figure 28. Europe Bronchitis Market Share by Application (2016-2027)
Figure 29. Europe Bronchitis Market Share by Country (2016-2027)
Figure 30. Germany Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bronchitis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bronchitis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bronchitis Market Share by Region (2016-2027)
Figure 40. China Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bronchitis Market Share by Type (2016-2027)
Figure 48. Latin America Bronchitis Market Share by Application (2016-2027)
Figure 49. Latin America Bronchitis Market Share by Country (2016-2027)
Figure 50. Mexico Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bronchitis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bronchitis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bronchitis Market Share by Country (2016-2027)
Figure 56. Turkey Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bronchitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Bronchitis Business (2016-2021)
Figure 60. Dr. Reddy’s Laboratories Revenue Growth Rate in Bronchitis Business (2016-2021)
Figure 61. GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Bronchitis Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Bronchitis Business (2016-2021)
Figure 63. Sanofi Aventis Revenue Growth Rate in Bronchitis Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の気管支炎治療市場規模・現状・予測（2021年-2027年） Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words, bronchitis is an inflammation of the lining of bronchial tubes that carry air to and from the lungs. Some of the common signs and symptoms of bronchitis include cough, fatigue, shortness o…- 世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の抗炎症療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-inflammatory Therapy Market The global Anti-inflammatory Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…